Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01847027 · ClinicalTrials.gov registry record · Phase 2
Exercise and NutraStem (NT-020): Effects on Stem Cells
A Phase 2 study, sponsored by University of North Texas Health Science Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT01847027: Completed Phase 2 study, sponsored by University of North Texas Health Science Center.
NCT01847027 is a Phase 2 study that has completed, run by University of North Texas Health Science Center. The registered enrollment target is 23 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01847027, a Phase 2 study, has completed, sponsored by University of North Texas Health Science Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to see if an investigational supplement called NutraStem® will increase the amount of stem cells in human blood at rest and after exercise. The ingredients found in NutraStem® can be found in nutrition or vitamin shops/stores.
Primary Outcome
The percentage of CD133+ cells detected in blood samples
Interventions
- DRUG Placebo
- DRUG NutraStem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-07-17 |
| Phase | Phase 2 |
What the finished NCT01847027 record still lists
NCT01847027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01847027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01847027 about?
NCT01847027 is a clinical study titled "Exercise and NutraStem (NT-020): Effects on Stem Cells". The purpose of this study is to see if an investigational supplement called NutraStem® will increase the amount of stem cells in human blood at rest and after exercise. The ingredients found in NutraStem® can be found in nutrition or vitamin shops/stores.
What is the current status of trial NCT01847027?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2013-04. Estimated completion is 2017-07-17.
What interventions are being tested in trial NCT01847027?
The interventions under investigation include: Placebo (DRUG), NutraStem (DRUG).
Who is sponsoring clinical trial NCT01847027?
This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01847027's enrollment target sits among peer trials
23 1784th of 2000 higher than 211 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia